Cross Historical Income Statement

CCRN Stock

USD 11.57 0.24 2.03%

Historical analysis of Cross Country income statement accounts such as Interest Expense of 5.9 M, Selling General Administrative of 318.6 M or Total Revenue of 2.1 B can show how well Cross Country Healthcare performed in making a profits. Evaluating Cross Country income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Cross Country's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Cross Country Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Cross Country Healthcare is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

About Cross Income Statement Analysis

Cross Country Healthcare Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Cross Country shareholders. The income statement also shows Cross investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Cross Country Income Statement Chart

At this time, Cross Country's Cost Of Revenue is very stable compared to the past year. As of the 26th of October 2024, Income Before Tax is likely to grow to about 108 M, while Depreciation And Amortization is likely to drop about 11.6 M.

Depreciation And Amortization Interest Expense Selling General Administrative Total Revenue Gross Profit

Depreciation And Amortization

The systematic reduction in the recorded value of an intangible asset. This includes the allocation of the cost of tangible assets to periods in which the assets are used, representing the expense related to the wear and tear, deterioration, or obsolescence of physical assets and intangible assets over their useful lives.

Interest Expense

The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.

Total Revenue

Total revenue comprises all receipts Cross Country Healthcare generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Cross Country Healthcare minus its cost of goods sold. It is profit before Cross Country operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Cross Country's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Cross Country Healthcare current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

	2021	2022	2023	2024 (projected)
Gross Profit	375.0M	627.7M	432.1M	216.1M
Total Revenue	1.7B	2.8B	2.0B	2.1B

Gross Profit Total Revenue

Cross Country income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling And Marketing Expenses	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Minority Interest	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.57	0.73	0.66	0.68	0.66	0.52	0.58	0.6	0.66	0.73	0.46	-0.18	0.42	0.41	-0.31	0.39	0.6	0.14	0.1	0.52	-0.62	-0.33	0.81	0.84
Interest Expense	0.57		0.81	0.86	0.93	0.85	0.82	0.9	0.9	0.86	0.83	0.79	-0.11	0.75	0.58	-0.29	0.69	0.4	-0.1	-0.16	0.69	-0.49	-0.73	0.41	0.54
Selling General Administrative	0.73	0.81		0.93	0.8	0.93	0.75	0.86	0.88	0.92	0.74	0.72	-0.12	0.68	0.54	-0.41	0.71	0.5	-0.05	-0.18	0.65	-0.65	-0.73	0.68	0.69
Total Revenue	0.66	0.86	0.93		0.9	1.0	0.94	0.94	0.94	1.0	0.84	0.92	0.09	0.87	0.67	-0.19	0.88	0.31	0.01	-0.39	0.76	-0.53	-0.86	0.58	0.69
Gross Profit	0.68	0.93	0.8	0.9		0.89	0.89	0.93	0.93	0.9	0.91	0.87	0.02	0.84	0.59	-0.23	0.81	0.35	0.03	-0.27	0.67	-0.51	-0.72	0.46	0.61
Other Operating Expenses	0.66	0.85	0.93	1.0	0.89		0.94	0.92	0.93	1.0	0.84	0.92	0.09	0.87	0.67	-0.16	0.88	0.32	0.02	-0.39	0.77	-0.53	-0.86	0.6	0.7
Operating Income	0.52	0.82	0.75	0.94	0.89	0.94		0.89	0.89	0.94	0.82	0.99	0.29	0.95	0.7	0.02	0.93	0.09	0.06	-0.51	0.76	-0.35	-0.85	0.4	0.58
Ebit	0.58	0.9	0.86	0.94	0.93	0.92	0.89		1.0	0.93	0.74	0.88	0.06	0.84	0.62	-0.41	0.84	0.26	-0.01	-0.37	0.68	-0.46	-0.77	0.38	0.58
Ebitda	0.6	0.9	0.88	0.94	0.93	0.93	0.89	1.0		0.94	0.74	0.88	0.05	0.84	0.62	-0.41	0.84	0.28	-0.01	-0.36	0.68	-0.47	-0.77	0.4	0.6
Cost Of Revenue	0.66	0.86	0.92	1.0	0.9	1.0	0.94	0.93	0.94		0.83	0.92	0.09	0.87	0.67	-0.18	0.88	0.3	0.02	-0.4	0.77	-0.52	-0.86	0.59	0.69
Total Operating Expenses	0.73	0.83	0.74	0.84	0.91	0.84	0.82	0.74	0.74	0.83		0.79	-0.01	0.77	0.54	0.06	0.72	0.44	0.07	-0.15	0.65	-0.57	-0.67	0.62	0.64
Income Before Tax	0.46	0.79	0.72	0.92	0.87	0.92	0.99	0.88	0.88	0.92	0.79		0.36	0.96	0.67	0.04	0.95	0.03	0.12	-0.56	0.72	-0.33	-0.86	0.34	0.53
Total Other Income Expense Net	-0.18	-0.11	-0.12	0.09	0.02	0.09	0.29	0.06	0.05	0.09	-0.01	0.36		0.39	0.11	0.33	0.45	-0.74	0.43	-0.62	0.03	0.29	-0.26	-0.18	-0.19
Net Income	0.42	0.75	0.68	0.87	0.84	0.87	0.95	0.84	0.84	0.87	0.77	0.96	0.39		0.46	0.07	0.96	0.05	0.14	-0.54	0.53	-0.4	-0.75	0.22	0.46
Income Tax Expense	0.41	0.58	0.54	0.67	0.59	0.67	0.7	0.62	0.62	0.67	0.54	0.67	0.11	0.46		-0.03	0.55	0.06	-0.01	-0.32	0.95	-0.05	-0.79	0.57	0.53
Selling And Marketing Expenses	-0.31	-0.29	-0.41	-0.19	-0.23	-0.16	0.02	-0.41	-0.41	-0.18	0.06	0.04	0.33	0.07	-0.03		-0.01	-0.28	0.18	-0.13	-0.01	0.2	-0.02	-0.1	-0.15
Net Income From Continuing Ops	0.39	0.69	0.71	0.88	0.81	0.88	0.93	0.84	0.84	0.88	0.72	0.95	0.45	0.96	0.55	-0.01		-0.01	0.15	-0.61	0.56	-0.35	-0.8	0.28	0.44
Non Recurring	0.6	0.4	0.5	0.31	0.35	0.32	0.09	0.26	0.28	0.3	0.44	0.03	-0.74	0.05	0.06	-0.28	-0.01		-0.05	0.53	0.16	-0.78	0.0	0.47	0.54
Non Operating Income Net Other	0.14	-0.1	-0.05	0.01	0.03	0.02	0.06	-0.01	-0.01	0.02	0.07	0.12	0.43	0.14	-0.01	0.18	0.15	-0.05		0.05	-0.03	-0.38	0.04	0.01	0.17
Minority Interest	0.1	-0.16	-0.18	-0.39	-0.27	-0.39	-0.51	-0.37	-0.36	-0.4	-0.15	-0.56	-0.62	-0.54	-0.32	-0.13	-0.61	0.53	0.05		-0.3	-0.34	0.57	0.05	0.03
Tax Provision	0.52	0.69	0.65	0.76	0.67	0.77	0.76	0.68	0.68	0.77	0.65	0.72	0.03	0.53	0.95	-0.01	0.56	0.16	-0.03	-0.3		-0.17	-0.84	0.66	0.63
Interest Income	-0.62	-0.49	-0.65	-0.53	-0.51	-0.53	-0.35	-0.46	-0.47	-0.52	-0.57	-0.33	0.29	-0.4	-0.05	0.2	-0.35	-0.78	-0.38	-0.34	-0.17		0.17	-0.42	-0.57
Net Interest Income	-0.33	-0.73	-0.73	-0.86	-0.72	-0.86	-0.85	-0.77	-0.77	-0.86	-0.67	-0.86	-0.26	-0.75	-0.79	-0.02	-0.8	0.0	0.04	0.57	-0.84	0.17		-0.49	-0.41
Reconciled Depreciation	0.81	0.41	0.68	0.58	0.46	0.6	0.4	0.38	0.4	0.59	0.62	0.34	-0.18	0.22	0.57	-0.1	0.28	0.47	0.01	0.05	0.66	-0.42	-0.49		0.72
Extraordinary Items	0.84	0.54	0.69	0.69	0.61	0.7	0.58	0.58	0.6	0.69	0.64	0.53	-0.19	0.46	0.53	-0.15	0.44	0.54	0.17	0.03	0.63	-0.57	-0.41	0.72

Click cells to compare fundamentals

Cross Country Account Relationship Matchups

Cross Country income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	14.1M	16.2M	12.3M	14.4M	18.3M	11.6M
Interest Expense	5.3M	2.9M	6.9M	14.4M	8.1M	5.9M
Selling General Administrative	174.1M	167.6M	205.8M	308.1M	303.5M	318.6M
Total Revenue	822.2M	836.4M	1.7B	2.8B	2.0B	2.1B
Gross Profit	204.0M	202.7M	375.0M	627.7M	432.1M	216.1M
Other Operating Expenses	814.2M	820.2M	1.5B	2.5B	1.9B	2.0B
Operating Income	8.0M	16.0M	139.3M	273.1M	117.1M	123.0M
Ebit	8.0M	12.4M	148.2M	290.4M	117.1M	123.0M
Ebitda	22.1M	28.6M	160.5M	304.8M	135.5M	142.2M
Cost Of Revenue	618.2M	633.7M	1.3B	2.2B	1.6B	1.7B
Total Operating Expenses	196.0M	186.5M	225.1M	336.8M	315.0M	184.5M
Income Before Tax	(24.2M)	(12.3M)	133.2M	256.3M	102.9M	108.0M
Total Other Income Expense Net	(32.3M)	(28.3M)	(6.1M)	(16.8M)	(14.2M)	(14.9M)
Net Income	(55.9M)	(12.1M)	132.0M	188.5M	72.6M	76.3M
Income Tax Expense	31.7M	(188K)	1.2M	67.9M	30.3M	31.8M
Net Income Applicable To Common Shares	(57.7M)	(13.0M)	132.0M	188.5M	216.7M	227.6M
Selling And Marketing Expenses	7.9M	6.2M	9.5M	16.1M	11.5M	11.2M
Net Income From Continuing Ops	(55.9M)	(12.1M)	132.0M	188.5M	102.4M	107.5M
Non Recurring	23.8M	25.3M	9.5M	17.1M	19.6M	16.1M
Non Operating Income Net Other	(3.2M)	(280K)	770K	(2.4M)	(2.8M)	(2.9M)
Minority Interest	1.3M	1.2M	1.8M	820K	(210K)	0.0
Tax Provision	31.7M	(188K)	1.2M	67.9M	33.9M	35.6M
Net Interest Income	(5.3M)	(2.9M)	(6.9M)	(14.4M)	(11.0M)	(11.6M)
Reconciled Depreciation	14.1M	12.7M	9.9M	12.6M	17.0M	13.9M

Pair Trading with Cross Country

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cross Country position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cross Country will appreciate offsetting losses from the drop in the long position's value.

Moving against Cross Stock

0.87	DOCS	Doximity	Pair Corr
0.72	ECOR	Electrocore LLC Trending	Pair Corr
0.6	EW	Edwards Lifesciences Corp	Pair Corr
0.6	VEEV	Veeva Systems Class	Pair Corr
0.44	FEMY	Femasys	Pair Corr

The ability to find closely correlated positions to Cross Country could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cross Country when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cross Country - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cross Country Healthcare to buy it.

The correlation of Cross Country is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cross Country moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cross Country Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Cross Country can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:

How To Invest In Cross

Details

Is Cross Stock a good investment?

Details

What is Cross Country's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cross Country. If investors know Cross will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cross Country listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.90)

Earnings Share

0.25

Revenue Per Share

45.794

Quarterly Revenue Growth

(0.37)

Return On Assets

0.0275

The market value of Cross Country Healthcare is measured differently than its book value, which is the value of Cross that is recorded on the company's balance sheet. Investors also form their own opinion of Cross Country's value that differs from its market value or its book value, called intrinsic value, which is Cross Country's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cross Country's market value can be influenced by many factors that don't directly affect Cross Country's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cross Country's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cross Country is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cross Country's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cross Historical Income Statement

About Cross Income Statement Analysis

Cross Country Income Statement Chart

Depreciation And Amortization

Interest Expense

Total Revenue

Gross Profit

Cross Country income statement Correlations

Cross Country Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cross Country income statement Accounts

Pair Trading with Cross Country

Moving against Cross Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 0.99	Operating Income
Net Income	+ 0.96	Income Before Tax

Net Interest Income	- 0.86	Income Before Tax
Net Interest Income	- 0.86	Cost Of Revenue
Net Interest Income	- 0.86	Other Operating Expenses
Net Interest Income	- 0.86	Total Revenue
Net Interest Income	- 0.85	Operating Income
Net Interest Income	- 0.84	Tax Provision